openPR Logo
Press release

Pain Management Device Market Demand Supply Analysis to 2023 | with Hospira Inc., Smiths Medical, Baxter International Inc., Boston Scientific Corporation, Medtronic Plc, etc

12-14-2018 02:10 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Pain Management Device Market

Pain Management Device Market

This research report titled “Global Pain Management Device Market Insights, forecast to 2023” has been added to the wide online database managed by Market Research Future. The study discusses the prime market growth factors along with future projections expected to impact the Global Pain Management Device Market during the period between 2018 and 2023.

Key Players for Global Pain Management Device Market

The Global Pain Management Devices Market thrives mostly on strategic moves that include merger, acquisition, collaboration, product launch and others. It benefits both the concerned company and the market.

Johnson & Johnson and Synthes recently announced their merger agreement in their attempt to create the world’s most innovative and comprehensive orthopedics business. This collaboration can assist the pain management devices market growth.

NeuroMetrix, in 2018 launched Quell 2.0, a 100% drug-free device that can be really effective in managing pains. Quell app has also been designed to make its operational facilities simple. The product is also smaller in size.

Grunenthal and KU Leuven joined hands in 2018 to develop a non-opioid pain treatment for painful diseases with a high unmet medical need.

Eminent players in the Global Pain Management Devices Market include Codman and Shurtleff, Inc. (U.S.), Stryker Corporation (U.S.), Hospira Inc. (U.S.), Smiths Medical (U.K.), Baxter International Inc. (U.S.), Boston Scientific Corporation (U.S.), Medtronic Plc (U.S.), St. Jude Medical (U.S.), Bio-Medical Research (BMR) Ltd. (U.K.), Kimberly-Clark Corporation (U.S.), DJO Global LLC (U.S.), B. Braun Melsungen AG. (Germany), Pain Management, Inc (U.S.), and others.

To Get Sample Report visit https://www.marketresearchfuture.com/sample_request/1504

Pain Management Device Market - Overview

The Pain Management Devices Market is getting excellent traction with booming healthcare sector. Disabilities caused by pain is frustrating and a liability for patients as it halts the normal efficacy of human being. Pain management devices are designed to mitigate or obliviate such pains and provide patients a stress-free life. The global pain management devices market is banking on that aspect and showing potentials to chart a course where its valuation would reach to USD 5.81 billion mark by 2023, asserts Market Research Future (MRFR). The report further predicts a 7.2% CAGR during the forecast period (2016-2023) and focuses on possible market drivers such as rise in mortality rate that also ensures a huge patient pool who are susceptible to wounds and contracts pain easily. Furthermore, increasing research & development activities and rising pain rehabilitation centers are bound to impact the pain management devices market with a great gusto.

Despite such efforts made by the healthcare sectors, the global pain management devices market can feel bottlenecked by the high cost involved with it. But the market can always find hope in companies making efforts to launch new products. The strategic move can invigorate the pain management devices market and hold it back from sliding down during the forecast period.

Industry News

Medtronic of Canada Ltd. has received a license from Health Canada for its Intellis™ platform. This includes the world's smallest implantable spinal cord stimulator (SCS) for the management of few types of chronic intractable pain. Given the issues of opioid abuse prevalent in the country, it has become mandatory for Canadians to have access to new non-opioid treatment options. One of these options includes adoption of SCS that provides effective and long-term pain relief while being a treatment option for patients who are interested in trying a non-drug alternative.

Segments for Global Pain Management Device Market

The Global Pain Management Devices Market can be segmented by stimulators, pumps, ablation devices, and application.

By stimulators, the pain management devices market can be segmented into neuromodulator devices and transcutaneous electrical nerve stimulation (TENS) devices. Neuromodulator devices can be further sub-segmented into spinal cord stimulator, intrathecal pain pump, peripheral nerve stimulator, dorsal root ganglion stimulation and other.

By pumps, the pain management devices market can be segmented into analgesic infusion pumps and other. Analgesic infusion pumps segment is further segmented into patient control infusion pumps, external infusion pumps, intrathecal infusion pumps and other.

Based on ablation devices, the pain management devices market can be further segmented into microwave devices, cryoablation devices and others.

On basis of application, the pain management devices market includes cancer pain, musculoskeletal pain, migraine, and others.

Regional Analysis for Global Pain Management Device Market

As per the report, the Global Pain Management Devices Market is spread across the regions of North America, Europe, Asia Pacific (APAC), and Middle East and Africa (MEA).

North America holds the maximum market share for pain management devices followed by Europe. The robust growth has been aided by huge investment and development in research & development. Moreover, the healthcare industry in the region has outperformed its peers from other regions which has ensured a smooth sailing ahead for the regional pain management devices market.

The APAC is growing at the fastest growth rate with the continuous efforts of the governments in the region to revamp the healthcare sector which ensures growth prospects of the market.

Europe observes a highly mature market in terms of revenue and size on account of favorable reimbursement, development of novel neuropathic pain management device and a large patient population base. Increasing healthcare awareness, along with growing healthcare expenditure in the region, are also playing their part in taking the market ahead.

The MEA markets is a bit topsy-turvy due to weak economic growth and lack of sophisticated healthcare infrastructure. However, the region is profiting much from government and private initiatives who are exploring the untapped possibilities for further growth.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/pain-management-devices-market-1504

Some Brief Table of Contents of Report

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

TOC Continued…

Do You Have Specific Requirement? Ask To Our Experts https://www.marketresearchfuture.com/enquiry/1504

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pain Management Device Market Demand Supply Analysis to 2023 | with Hospira Inc., Smiths Medical, Baxter International Inc., Boston Scientific Corporation, Medtronic Plc, etc here

News-ID: 1441745 • Views:

More Releases from Market Research Future

Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing Your Business with Market Size
Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing You …
Hydrofluoric acid (HF) is a crucial chemical compound with a wide range of applications across various industries. Despite its hazardous nature, it plays an essential role in manufacturing processes, especially in the production of fluorine compounds. The global hydrofluoric acid market has been witnessing steady growth, driven by demand from end-user industries such as oil refining, pharmaceuticals, and electronics. The Hydrodesulfurization Catalysts Market is projected to register a CAGR of over
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reaching USD 2.4 billion by 2030
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reachi …
In recent years, the global market for palm methyl ester derivatives has witnessed significant growth, driven by various factors including environmental concerns, technological advancements, and the increasing demand for sustainable alternatives in various industries. Palm methyl ester derivatives, derived from palm oil, have emerged as versatile ingredients with applications spanning across sectors such as cosmetics, pharmaceuticals, lubricants, and more. The Palm Methyl Ester Derivative Market Size was valued at USD 1.5
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 2032: Analysis by Segmentation, Competitors Analysis
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 20 …
The Asia-Pacific ceramic tiles market has been witnessing robust growth, driven by various factors such as increasing investments in residential and commercial construction, renovation activities, and the growing preference for aesthetically pleasing and durable flooring solutions. Countries like China, India, Japan, and South Korea have been leading the market growth, supported by strong manufacturing capabilities, technological advancements, and evolving consumer preferences. Asia-Pacific Ceramic Tiles Market Size was valued at USD 141.2
APAC Wallpaper Market to Register Highest CAGR Growth of 8% by 2032: Analysis by Segmentation, Competitors Analysis
APAC Wallpaper Market to Register Highest CAGR Growth of 8% by 2032: Analysis by …
The APAC wallpaper market has witnessed significant growth in recent years, driven by factors such as rising disposable incomes, expanding construction activities, and growing awareness regarding interior decor. Countries like China, India, Japan, South Korea, and Australia have emerged as key contributors to the region's wallpaper market. Additionally, the increasing adoption of innovative wallpaper designs and patterns is fueling market growth further. APAC Wallpaper Market Size was valued at USD 0.55

All 5 Releases


More Releases for Pain

Global Pain Management Devices Market Study Analysis: Adoption Of Pain Managemen …
The fast-food market size was valued at $ billion in 2020 and is estimated to reach $ billion by 2028, growing at a CAGR of 6.3% during the forecast period. Pain is an unpleasant sensation and emotional experience caused due to actual or potential tissue damage or illness. Pain can be caused due to accidental injuries, or due to diseases like osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcer,
Flexotone Joint Pain Relief Reviews: Get Relief from Joint Pain & Arthritis
Joint pain & inflammation has come to be an instead usual problem among older consumers, as well as they are frequently entrusted to identify exactly how to deal with these problems with a topical cream or resting. Nevertheless, the makers behind Flexotone think that the reason behind this concern has every little thing to do with something that takes place within the joints. This trouble triggers unbelievable pain; however Big
Nerve Pain Treatment: 3 Top Neuropathy Pain Relief Pills
Neuropathy affects your extremities or nerves by producing tingling, discomfort, or numbness. Diabetics frequently suffer from neuropathy. According to the American Diabetes Association, around 65 percent of people suffering from diabetes face varying degrees of nerve damage, which results in diabetic neuropathy. Neuropathy can also occur due to different reasons, like alcoholism, trauma, or autoimmune disorders. Some people acquire neuropathy due to physical injury to their nerves, for instance. Others have
Post-operative Pain Management Market 2018 by Pain Type - Acute Pain, Moderate P …
Post-operative Pain Management Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Post-operative Pain Management Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023. Global Post-operative Pain Management Market - Overview Post-operative pain management is the most important part
Opioids – Reducing body pain but increasing pain for regulatory authorities
Opioids are drugs primarily prescribed for pain management and treatment of diarrhea and cough. Opioid drugs are of two types namely, agonist and antagonist. Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone, Diphenoxylate, Hydromorphone, Methylphenidate, Oxycodone, and Oxymorphone are classified as agonists, while Buprenorphine, Naloxone, Naltrexone, Methylnaltrexone, and Nalbuphine are classified as antagonists. Due to easy availability of opioids, these drugs are rampantly overused globally and the situation is more critical in
Middle East Tapentadol Market by Therapeutic Application Pain Management Neuropa …
Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative treatment options are inadequate. Tapentadol is also indicated for neuropathic pain associated with diabetic peripheral neuropathy. It is widely used for management of acute, chronic, and cancer related pain among patients and is available legally on prescription. Nucynta ER is the first and